Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2021-09-14 14:58:03 UTC |
---|
HMDB ID | HMDB0000901 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Valproic acid glucuronide |
---|
Description | Valproic acid glucuronide is the glucuronidation product of valproic acid. Valproic acid, or 2-Propylpentanoic acid, is a chemical compound that has found clinical use as an anticonvulsant and mood-stabilizing drug, primarily in the treatment of epilepsy and bipolar disorder, but also used to treat migraine headaches and schizophrenia. In epileptics, valproic acid is used to control absence seizures, tonic-clonic seizures (grand mal), complex partial seizures, and the seizures associated with Lennox-Gastaut syndrome. Glucuronidation is a vital phase 2 metabolic (conjugative) process by which a wide range of drugs and other xenobiotics may be rendered water-soluble, detoxified and excreted. Acyl (ester) glucuronides (AGs) of carboxylic acids are potentially reactive metabolites. In particular, AGs are important phase 2 metabolites for a wide range of carboxylic acid-containing drugs. (PMID: 18201150 , 17496767 , 17496206 ). |
---|
Structure | CCCC(CCC)C(=O)O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O InChI=1S/C14H24O8/c1-3-5-7(6-4-2)13(20)22-14-10(17)8(15)9(16)11(21-14)12(18)19/h7-11,14-17H,3-6H2,1-2H3,(H,18,19)/t8-,9-,10+,11-,14-/m0/s1 |
---|
Synonyms | Value | Source |
---|
Valproate glucuronide | Generator | 1-(2-Propylpentanoate | HMDB | 1-(2-Propylpentanoate) beta-D-glucopyranuronate | HMDB | 1-(2-Propylpentanoate) beta-D-glucopyranuronic acid | HMDB | 1-(2-Propylpentanoate) beta-delta-glucopyranuronate | HMDB | 1-(2-Propylpentanoate) beta-delta-glucopyranuronic acid | HMDB | 1-(2-Propylpentanoic acid | HMDB | 1-O-Valproyl-b-D-glucopyranuronic acid | HMDB | 1-O-Valproyl-beta-delta-glucopyranuronic acid | HMDB | 3,4,5-Trihydroxy-6-(2-propyl-pentanoyloxy)-tetrahydro-pyran-2-carboxylate | HMDB | 3,4,5-Trihydroxy-6-(2-propyl-pentanoyloxy)-tetrahydro-pyran-2-carboxylic acid | HMDB | Dipropylacetate glucuronide | HMDB | Myproate | HMDB | Myproic acid | HMDB | Valproate | HMDB | Valproic acid | HMDB | VPA-g | HMDB | VPAG | HMDB |
|
---|
Chemical Formula | C14H24O8 |
---|
Average Molecular Weight | 320.3356 |
---|
Monoisotopic Molecular Weight | 320.147117744 |
---|
IUPAC Name | (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-propylpentanoyl)oxy]oxane-2-carboxylic acid |
---|
Traditional Name | (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-propylpentanoyl)oxy]oxane-2-carboxylic acid |
---|
CAS Registry Number | 60113-83-9 |
---|
SMILES | CCCC(CCC)C(=O)O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O |
---|
InChI Identifier | InChI=1S/C14H24O8/c1-3-5-7(6-4-2)13(20)22-14-10(17)8(15)9(16)11(21-14)12(18)19/h7-11,14-17H,3-6H2,1-2H3,(H,18,19)/t8-,9-,10+,11-,14-/m0/s1 |
---|
InChI Key | XXKSYIHWRBBHIC-JVWRJRKNSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as o-glucuronides. These are glucuronides in which the aglycone is linked to the carbohydrate unit through an O-glycosidic bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Carbohydrates and carbohydrate conjugates |
---|
Direct Parent | O-glucuronides |
---|
Alternative Parents | |
---|
Substituents | - 1-o-glucuronide
- O-glucuronide
- Beta-hydroxy acid
- Fatty acid ester
- Dicarboxylic acid or derivatives
- Hydroxy acid
- Monosaccharide
- Fatty acyl
- Oxane
- Pyran
- Carboxylic acid ester
- Secondary alcohol
- Oxacycle
- Acetal
- Carboxylic acid
- Polyol
- Carboxylic acid derivative
- Organoheterocyclic compound
- Alcohol
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | 0.85 | Extrapolated |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Valproic acid glucuronide,1TMS,isomer #1 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]1O | 2217.1 | Semi standard non polar | 33892256 | Valproic acid glucuronide,1TMS,isomer #2 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]1O | 2226.3 | Semi standard non polar | 33892256 | Valproic acid glucuronide,1TMS,isomer #3 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O[Si](C)(C)C | 2206.4 | Semi standard non polar | 33892256 | Valproic acid glucuronide,1TMS,isomer #4 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]1O | 2197.7 | Semi standard non polar | 33892256 | Valproic acid glucuronide,2TMS,isomer #1 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]1O | 2218.3 | Semi standard non polar | 33892256 | Valproic acid glucuronide,2TMS,isomer #2 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]1O | 2247.8 | Semi standard non polar | 33892256 | Valproic acid glucuronide,2TMS,isomer #3 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]1O[Si](C)(C)C | 2255.4 | Semi standard non polar | 33892256 | Valproic acid glucuronide,2TMS,isomer #4 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]1O | 2256.7 | Semi standard non polar | 33892256 | Valproic acid glucuronide,2TMS,isomer #5 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C | 2247.1 | Semi standard non polar | 33892256 | Valproic acid glucuronide,2TMS,isomer #6 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]1O[Si](C)(C)C | 2212.5 | Semi standard non polar | 33892256 | Valproic acid glucuronide,3TMS,isomer #1 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]1O | 2290.7 | Semi standard non polar | 33892256 | Valproic acid glucuronide,3TMS,isomer #2 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]1O[Si](C)(C)C | 2323.0 | Semi standard non polar | 33892256 | Valproic acid glucuronide,3TMS,isomer #3 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C | 2275.8 | Semi standard non polar | 33892256 | Valproic acid glucuronide,3TMS,isomer #4 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C | 2292.0 | Semi standard non polar | 33892256 | Valproic acid glucuronide,4TMS,isomer #1 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C | 2320.3 | Semi standard non polar | 33892256 | Valproic acid glucuronide,1TBDMS,isomer #1 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]1O | 2461.4 | Semi standard non polar | 33892256 | Valproic acid glucuronide,1TBDMS,isomer #2 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O | 2468.3 | Semi standard non polar | 33892256 | Valproic acid glucuronide,1TBDMS,isomer #3 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O[Si](C)(C)C(C)(C)C | 2468.7 | Semi standard non polar | 33892256 | Valproic acid glucuronide,1TBDMS,isomer #4 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]1O | 2462.8 | Semi standard non polar | 33892256 | Valproic acid glucuronide,2TBDMS,isomer #1 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]1O | 2715.8 | Semi standard non polar | 33892256 | Valproic acid glucuronide,2TBDMS,isomer #2 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O | 2710.9 | Semi standard non polar | 33892256 | Valproic acid glucuronide,2TBDMS,isomer #3 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]1O[Si](C)(C)C(C)(C)C | 2719.9 | Semi standard non polar | 33892256 | Valproic acid glucuronide,2TBDMS,isomer #4 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O | 2730.3 | Semi standard non polar | 33892256 | Valproic acid glucuronide,2TBDMS,isomer #5 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C | 2714.5 | Semi standard non polar | 33892256 | Valproic acid glucuronide,2TBDMS,isomer #6 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]1O[Si](C)(C)C(C)(C)C | 2721.8 | Semi standard non polar | 33892256 | Valproic acid glucuronide,3TBDMS,isomer #1 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O | 2959.7 | Semi standard non polar | 33892256 | Valproic acid glucuronide,3TBDMS,isomer #2 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]1O[Si](C)(C)C(C)(C)C | 2994.6 | Semi standard non polar | 33892256 | Valproic acid glucuronide,3TBDMS,isomer #3 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C | 2943.4 | Semi standard non polar | 33892256 | Valproic acid glucuronide,3TBDMS,isomer #4 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C | 2966.7 | Semi standard non polar | 33892256 | Valproic acid glucuronide,4TBDMS,isomer #1 | CCCC(CCC)C(=O)O[C@@H]1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C | 3200.7 | Semi standard non polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0pds-9221000000-c4a088ea62b38f27162d | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (4 TMS) - 70eV, Positive | splash10-0006-7101290000-cfd964bab66e1a7f52c7 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TMS_3_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Valproic acid glucuronide GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valproic acid glucuronide 10V, Positive-QTOF | splash10-004j-0902000000-2aede4223010fbfa28cd | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valproic acid glucuronide 20V, Positive-QTOF | splash10-004j-4900000000-8d4033ca0760506b6c4e | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valproic acid glucuronide 40V, Positive-QTOF | splash10-002e-9700000000-9b150785b1449fefe60e | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valproic acid glucuronide 10V, Negative-QTOF | splash10-00mo-2913000000-c1208d610d940b866f24 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valproic acid glucuronide 20V, Negative-QTOF | splash10-002f-4910000000-881718af4775dafc78f3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valproic acid glucuronide 40V, Negative-QTOF | splash10-0006-9700000000-2d69130ba045cf068e49 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valproic acid glucuronide 10V, Positive-QTOF | splash10-00di-1209000000-1fe9a50772ce5d04154f | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valproic acid glucuronide 20V, Positive-QTOF | splash10-0a4s-9301000000-7e6b8c6eaca54df62353 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valproic acid glucuronide 40V, Positive-QTOF | splash10-0a4r-9100000000-b293f27db4ba83db2396 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valproic acid glucuronide 10V, Negative-QTOF | splash10-014i-0109000000-980c74ef8113693a80e1 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valproic acid glucuronide 20V, Negative-QTOF | splash10-00mp-3901000000-192aebcbdfefe9b795c9 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valproic acid glucuronide 40V, Negative-QTOF | splash10-052e-9400000000-1078233b81443bce6776 | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane
|
---|
Biospecimen Locations | |
---|
Tissue Locations | - Adipose Tissue
- Brain
- Kidney
- Liver
- Pancreas
- Placenta
- Platelet
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022308 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | 2991 |
---|
PubChem Compound | 88111 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Yamamura, Naotoshi; Muramatsu, Shigeki; Suzuki, Kanae; Uchiyama, Minoru; Nakajima, Eiichi. High-yield, enzymic synthesis of 14C- or 3H-labeled 1-O-valproyl-b-D-glucopyranuronic acid, the main metabolite of valproic acid in human. Radioisotopes (1999), 48( |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Nemeroff CB: The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull. 2003;37(4):133-46. [PubMed:15131523 ]
- Bell EC, Willson MC, Wilman AH, Dave S, Silverstone PH: Differential effects of chronic lithium and valproate on brain activation in healthy volunteers. Hum Psychopharmacol. 2005 Aug;20(6):415-24. [PubMed:16106488 ]
- Sztajnkrycer MD: Valproic acid toxicity: overview and management. J Toxicol Clin Toxicol. 2002;40(6):789-801. [PubMed:12475192 ]
- Yoshida H, Hirozane K, Kimoto H, Hayashi T, Akiyama T, Katayama H, Watanabe M, Yoshitomi H, Kamiya A: Valproic acid elimination rate and urinary excretion of its glucuronide conjugate in patients with epilepsy. Biol Pharm Bull. 1999 Jul;22(7):716-20. [PubMed:10443469 ]
- Seyfert S, Bernarding J, Braun J: Volume-selective 1H MR spectroscopy for in vivo detection of valproate in patients with epilepsy. Neuroradiology. 2003 May;45(5):295-9. Epub 2003 Mar 27. [PubMed:12669157 ]
- Eyal S, Lamb JG, Smith-Yockman M, Yagen B, Fibach E, Altschuler Y, White HS, Bialer M: The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver. Br J Pharmacol. 2006 Oct;149(3):250-60. Epub 2006 Aug 7. [PubMed:16894351 ]
- Bailey DN, Briggs JR: Valproic acid binding to human serum and human placenta in vitro. Ther Drug Monit. 2005 Jun;27(3):375-7. [PubMed:15905810 ]
- Safford KM, Hicok KC, Safford SD, Halvorsen YD, Wilkison WO, Gimble JM, Rice HE: Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun. 2002 Jun 7;294(2):371-9. [PubMed:12051722 ]
- Queizan A, Hernandez F, Rivas S: Pancreatic pseudocyst caused by valproic acid: case report and review of the literature. Eur J Pediatr Surg. 2003 Feb;13(1):60-2. [PubMed:12664419 ]
- Loscher W: Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs. 2002;16(10):669-94. [PubMed:12269861 ]
- Fowler DW, Eadie MJ, Dickinson RG: Transplacental transfer and biotransformation studies of valproic acid and its glucuronide(s) in the perfused human placenta. J Pharmacol Exp Ther. 1989 Apr;249(1):318-23. [PubMed:2496226 ]
- Serdaroglu G, Erhan E, Tekgul H, Oksel F, Erermis S, Uyar M, Tutuncuoglu S: Sodium valproate prophylaxis in childhood migraine. Headache. 2002 Sep;42(8):819-22. [PubMed:12390647 ]
- Kim JM, Jung KY, Choi CM: Changes in brain complexity during valproate treatment in patients with partial epilepsy. Neuropsychobiology. 2002;45(2):106-12. [PubMed:11893868 ]
- Huang YL, Hong HS, Wang ZW, Kuo TT: Fatal sodium valproate-induced hypersensitivity syndrome with lichenoid dermatitis and fulminant hepatitis. J Am Acad Dermatol. 2003 Aug;49(2):316-9. [PubMed:12894087 ]
- Dickinson RG, Kluck RM, Hooper WD, Patterson M, Chalk JB, Eadie MJ: Rearrangement of valproate glucuronide in a patient with drug-associated hepatobiliary and renal dysfunction. Epilepsia. 1985 Nov-Dec;26(6):589-93. [PubMed:3935422 ]
- Williams AM, Worrall S, de Jersey J, Dickinson RG: Studies on the reactivity of acyl glucuronides--III. Glucuronide-derived adducts of valproic acid and plasma protein and anti-adduct antibodies in humans. Biochem Pharmacol. 1992 Feb 18;43(4):745-55. [PubMed:1540228 ]
- Nakamura H, Ushigome F, Koyabu N, Satoh S, Tsukimori K, Nakano H, Ohtani H, Sawada Y: Proton gradient-dependent transport of valproic acid in human placental brush-border membrane vesicles. Pharm Res. 2002 Feb;19(2):154-61. [PubMed:11883642 ]
- De Berardis D, Campanella D, Matera V, Gambi F, La Rovere R, Sepede G, Grimaldi MR, Pacilli AM, Salerno RM, Ferro FM: Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder. J Clin Psychopharmacol. 2003 Oct;23(5):451-8. [PubMed:14520121 ]
- Anderson GD, Temkin NR, Chandler WL, Winn HR: Effect of valproate on hemostatic function in patients with traumatic brain injury. Epilepsy Res. 2003 Dec;57(2-3):111-9. [PubMed:15013052 ]
- Mallet L, Babin S, Morais JA: Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman. Ann Pharmacother. 2004 Oct;38(10):1643-7. Epub 2004 Aug 17. [PubMed:15316109 ]
- Wong H, Tong V, Riggs KW, Rurak DW, Abbott FS, Kumar S: Kinetics of valproic acid glucuronidation: evidence for in vivo autoactivation. Drug Metab Dispos. 2007 Aug;35(8):1380-6. Epub 2007 May 11. [PubMed:17496206 ]
- Gerstner T, Bell N, Konig S: Oral valproic acid for epilepsy--long-term experience in therapy and side effects. Expert Opin Pharmacother. 2008 Feb;9(2):285-92. doi: 10.1517/14656566.9.2.285 . [PubMed:18201150 ]
- Russell S: Carnitine as an antidote for acute valproate toxicity in children. Curr Opin Pediatr. 2007 Apr;19(2):206-10. [PubMed:17496767 ]
|
---|